Warning Letter Wednesday Posts

A weekly exploration of FDA warning letters and enforcement trends


April 15, 2026
Takeaway -

Advertising net impression is important to consider

April 8, 2026
Takeaway -

Sketchy weight loss product attracts attention

April 1, 2026
Takeaway -

The NAD+ battles continue

March 25, 2026
Takeaway -

Use caution when making public statements

March 18, 2026
Takeaway -

Train all social media staff in the nuances of implied claims

March 11, 2026
Takeaway -

Review clinical study parameters with experts

March 4, 2026
Takeaway -

Net impression and context matter

February 25, 2026
Takeaway -

Importance of compliance & testing

February 18, 2026
Takeaway -

Risky product category + disease claims = warning letter

February 4, 2026
Takeaway -

Ensure 483 responses are complete

January 28, 2026
Takeaway -

Ensure all data is defensible when making comparisons